Blood particles may predict chemo nerve pain
NCT ID NCT07558447
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether tiny particles in the blood, called extracellular vesicles, can predict nerve damage caused by chemotherapy. Researchers will follow 120 adults with various cancers who are receiving specific chemo drugs. Participants give blood samples and answer questionnaires before, during, and after treatment. The goal is to find a way to identify patients at higher risk for nerve damage, so doctors can monitor and manage it better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SC Oncologia Medica Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
RECRUITINGMilan, 20122, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?